Jakafi 20 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26FCYZ4
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,677
Award facts
- Contract value 100% obligated
- $24,676.82 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $24,676.82 to DMS Pharmaceutical Group Inc. for 60 tablets of JAKAFI 20 mg, a prescription medication used in the treatment of certain blood disorders and cancers. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected through firm fixed-price pricing with an ultimate completion date of December 4, 2025. The award carries no set-aside designation, indicating the contractor competed in an unrestricted procurement process. The place of performance is Park Ridge, IL 60068, where the vendor maintains its headquarters and operations.
This delivery order was issued under DMS Pharmaceutical Group's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to provide comprehensive pharmaceutical supply chain support to Department of Defense military healthcare facilities worldwide. DMS Pharmaceutical Group's IDC, designated SPE2DR and awarded on November 13, 2025, carries a ceiling value of $499,999,999 with a performance period extending through December 31, 2036. The contract structure enables the Defense Logistics Agency to issue multiple delivery orders for branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to support recurring medical supply requirements across the federal military medical system globally.
Quick answers
Who was awarded contract SPE2DR26FCYZ4?
SPE2DR26FCYZ4 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 3, 2025.
How much is contract SPE2DR26FCYZ4 worth?
The government has obligated $24,677 on SPE2DR26FCYZ4.
Is contract SPE2DR26FCYZ4 an order under another contract?
Yes. SPE2DR26FCYZ4 is a delivery order under SPE2DR25D9127, an indefinite delivery contract.
Was contract SPE2DR26FCYZ4 competed?
The extent of competition for SPE2DR26FCYZ4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award